|
Notable Gender, Racial Disparities Exist among U.S. Clinical Investigators
November 13, 2007
Despite more cancer drugs in R&D, overall U.S. approval rate is 8%
September 5, 2007
Follow–on drugs and indications play key role for World Health Organization
July 10, 2007
Results Mixed on Postmarketing Studies of New Drugs
May 15, 2007
Big Pharma–Biotech Partnering Holds Promise for Improving R&D Productivity
March 26, 2007
Pediatric Study Costs Rose Substantially from 2000 as Complexity Grew
March 13, 2007
European Union Meeting Performance Goals for New Drug Review, But Lags Behind U.S. in New Drug Availability
January 16, 2007
Despite Development Challenges, Drug Developers Have Reason to be Optimistic
January 3, 2007
Return to Top
|